Study of usefulness of budesonide nebulization in oxygen dependent preterm newborns in NICU

Authors

  • Rajith M. L. Department of Pediatrics, Sri Siddhartha Medical College, Agalakote, Tumkur, Karnataka, India
  • Punyashree R. Department of Obstetrics and Gynecology, Siddaganga Medical College and Research Institute, Tumkur, Karnataka, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20240924

Keywords:

Respiratory distress, Budesonide, Inhaled, Neonate, Meconium aspiration syndrome

Abstract

Background: Increased duration of neonatal intensive care unit (NICU) stay of preterm neonates have becoming an emotional and financial burden to parents leading to very high chances of parents discontinuing the treatment and thus increased morbidity and mortality of neonates. Oxygen dependency is the major cause of the prolonged NICU stay for the neonates having respiratory illness like respiratory distress syndrome (RDS), meconium aspiration syndrome (MAS), and pneumonia. Inhaled budesonide being a safe immunosuppressor has shown the promising result in the treatment of these immune system activated respiratory disorders of neonate and thus reduction of oxygen dependency and later reducing the hospital stay duration. The intent of this study is to evaluate the usefulness of inhaled budesonide in such respiratory disorders of neonate.

Methods: A randomized controlled trial involving 60 oxygen dependent neonates in NICU was conducted from July 2021 to March 2023.

Results: Budesonide nebulization decreased the duration of oxygen dependency of neonates and thus reduced NICU stay.

Conclusions: Budesonide nebulization is associated with improvements in respiratory parameters in neonates with RDS, MAS, Pneumonia leading to early oxygen weaning and early discharge.

References

Ye W, Zhang T, Shu Y, Fang C, Xie L, Peng K, et al. The influence factors of neo- natal respiratory distress syndrome in Southern China: a case-control study. J Matern Fetal Neonatal Med. 2020;33(10):1678-82.

Kothe TB, Sadiq FH, Burleyson N, Williams HL, Anderson C, Hillman NH. Surfactant and budesonide for respiratory distress syndrome: an observational study. Pediatr Res. 2020;87(5):940-5.

De Bernardo G, De Santis R, Giordano M, Sordino D, Buonocore G, Perrone S. Predict respiratory distress syndrome by umbilical cord blood gas analysis in newborns with reassuring Apgar score. Ital J Pediatr. 2020;46(1):20.

Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Investig. 2012;122(8):2731-40.

Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.

Kemp MW, Newnham JP, Challis JG, Jobe AH, Stock SJ. The clinical use of corticosteroids in pregnancy. Hum Reprod Update. 2016;22(2):240-59.

Mirzamoradi M, Joshaghani Z, Hasani NF, Vafaeenia M, Heidar Z. Evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidity in early-term elective caesarean. J Matern Fetal Neonatal Med. 2020;33(12):1994-9.

Garbrecht MR, Klein JM, Schmidt TJ, Snyder JM. Glucocorticoid metabolism in the human fetal lung: implications for lung development and the pulmonary surfactant system. Biol Neonate. 2006;89(2):109-19.

Ma H, Yan W, Liu J. Diagnostic value of lung ultrasound for neonatal respiratory distress syndrome: a meta-analysis and systematic review. Med Ultrasound. 2020;22(3):325-33.

Speer CP. Neonatal respiratory distress syndrome: an inflammatory disease? Neonatology. 2011;99(4):316-9.

Li L, Dong L, Zhao D, Gao F, Yan J. Classical dendritic cells regulate acute lung inflammation and injury in mice with lipopolysaccharide induced acute respiratory distress syndrome. Int J Mol Med. 2019;44(2):617–629.

Westover AJ, Moss TJ. Effects of intrauterine infection or inflammation on fetal lung development. Clin Exp Pharmacol Physiol. 2012;39(9):824-30.

Zhu HP, Huang HY, Wu DM, Dong N, Dong L, Chen CS, et al. Regulatory mechanism of NOV/CCN3 in the inflammation and apoptosis of lung epithelial alveolar cells upon lipopolysaccharide stimulation. Mol Med Rep. 2020;21(4):1872-80.

Yang D, Yang Y, Zhao Y. Ibudilast, a phosphodiesterase-4 inhibitor, ameliorates acute respiratory distress syndrome in neonatal mice by alleviating inflammation and apoptosis. Med Sci Monit. 2020;26:e922281.

Poets CF, Lorenz L. Prevention of bronchopulmonary dysplasia in extremely low gestational age neonates: current evidence. Arch Dis Child Fetal Neonatal Ed. 2018;103(3):F285-91.

Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Early (<7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;10(10):CD001146.

Venkataraman R, Kamaluddeen M, Hasan SU, Robertson HL, Lodha A. Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta- analysis. Pediatr Pulmonol. 2017;52(7):968-75.

Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D. Inhaled corticosteroids for bronchopulmonary dysplasia: a meta- analysis. Pediatrics. 2016;138(6):e20162511.

Filippone M, Nardo D, Bonadies L, Salvadori S, Baraldi E. Update on post- natal corticosteroids to prevent or treat bronchopulmonary dysplasia. Am J Perinatol. 2019;36(S 02):S58-62.

Fanaroff AA. Meconium aspiration syndrome: historical aspects. J Perinatol. 2008;28(3):S3-7.

Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome: an update. Pediatr Clin North Am. 1998;45(3)511-29.

Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol. 2012;33(3):250-6.

Dai Q, Duan C, Liu Q, Yu H. Effect of nebulized budesonide on decreasing the recurrence of allergic fungal rhinosinusitis. Am J Otolaryngol. 2017;38(3):321-4.

Gao W, Ju YN. Budesonide attenuates ventilator-induced lung injury in a rat model of inflammatory acute respiratory distress syndrome. Arch Med Res. 2016;47(4):275-84.

Shen KL, Deng LI, Li YZ, Li CC, Liu EM, Chen Q, et al. Expert consensus on the application of glucocorticoids atomization inhalation in department of pediatrics. J Clin Pediatr. 2014;32(6):504-10.

Sadeghnia A, Beheshti BK, Mohammadizadeh M. The effect of inhaled budesonide on the prevention of chronic lung disease in premature neonates with respiratory distress syndrome. Int J Prev Med. 2018;9:15.

Kopincova J, Calkovska A. Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms. Pediatr Res. 2016;79(4):514-8.

Zagariya A, Bhat R, Navale S, Vidyasagar D. Cytokine expression in meconium-induced lungs. Indian J Pediatr. 2004;71(3):195-201.

Kojima T, Hattori K, Fujiwara T, Sasai-Takedatsu, M, Kobayashi Y. Meconium induced lung injurymediated by activation of alveolar macrophages. Life Sci. 1994;54(21):1559-62.

Shinwell ES, Portnov I, Meerpohl JJ, Karen T, Bassler D. Inhaled corticosteroids for bronchopulmonary dysplasia: a meta-analysis. Pediatrics. 2016;138(6):20162511.

Downloads

Published

2024-04-04

Issue

Section

Original Research Articles